Recent News in Regulatory Landscape
Date: June 11, 2026
The ACDM Regulatory Considerations DMEG have kindly put together a short news piece detailing recent news across the regulatory landscape in Clinical Data Management.
Read their update here:
Exciting news in the regulatory space! ICH released ICH E6 R3 Annex 2 on June 3, 2026. According to the introduction Annex 2 supplements R3 and Annex 1 approach to applying risk proportionate approaches to trial design and conduct. Annex 2 expands on this with a focus on decentralized trials approaches, pragmatic elements and real-world data (RWD).
The ACDM DMEG on Regulatory Considerations is looking forward to reviewing Annex 2 and publishing a summary of the highlights that impact data management. But in the interim we wanted to share the document with you. You can access the document using the link below.
https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Annex%202_Guideline_Step%204_2026_0603_0.pdf
The Regulatory Considerations Expert Group provides guidance on a range of topics related to regulatory frameworks in clinical data management. This includes where to find applicable regulations, how to stay informed about new and emerging requirements, and which specific areas are relevant to data management, along with what they mean in practice. Find out more about their work here: https://acdmglobal.org/regulatory-considerations-dmeg/
Explore More News
Regulatory Considerations DMEG Update – September 2024
The Regulatory Considerations DMEG are waiting for the release of ICH GCP E6 (R3) Annex 1 . . .
Read More
Digital Data Flow (DDF) integration through the lens of electronic Patient-Reported Outcomes (ePRO)
This article has been submitted by Leeni Joshua of ICON plc
Introduction:
Digital Data . . .
Read More
Guidance for Industry: Conducting Clinical Trials With Decentralized Elements
The Conducting Clinical Trials With Decentralized Elements final guidance has now been . . .
Read More
Welcome FGK Clinical Research as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome FGK Clinical . . .
Read More
Welcome LINK Medical as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome LINK Medical as . . .
Read More
Welcome Zilla Clinicals as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Zilla Clinicals . . .
Read More
Challenge ChatGPT: CDMs vs AI
Following a recent Hot Topic discussion that explained how machine learning models are . . .
Read More
Welcome Boehringer Ingelheim as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Boehringer . . .
Read More
Welcome Datacapt as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Datacapt as a . . .
Read More
Welcome Climedo as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Climedo as a . . .
Read More
Clinical Trials for Medicines – New Notification Scheme
The MHRA have recently launched a new notification scheme, the first step in their . . .
Read More
EMA Management Board: Highlights of October 2023 meeting
The EMA’s Management Board met on 5 October in Amsterdam. The article below covers the . . .
Read More
